Pregnant women may soon be able to assess their own risk of preeclampsia, according to work published in the Journal of Engineering and Science in Medical Diagnostics and Therapy. 

A novel machine learning algorithm improved patient selection for CRT in a study of nearly 1,000 heart failure patients, representing an opportunity to optimize care and spare certain individuals from a pricey procedure that might not benefit them.

Pharmaceutical company AstraZeneca announced Oct. 21 that its drug Farxiga—or dapagliflozin—was approved by the FDA to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes.

Short-term opioid prescriptions could have long-term consequences for heart patients with cardiac implantable electronic devices, according to work published in Heart Rhythm Oct. 21.

The Bristol-Myers Squibb-Pfizer Alliance and Fitbit on Oct. 17 announced they’d be partnering to improve timely diagnosis of atrial fibrillation in people at an increased risk of stroke.

An implantable cardiac monitor designed to alert patients with coronary artery disease to progressive, abnormal ST-segment shifts could expedite transport to the ED and reduce treatment delays during acute coronary syndromes, according to work published in the Journal of the American College of Cardiology.

Despite a litany of bad press in recent months, a study published Oct. 17 in Addiction suggests e-cigarettes help some 50,000 smokers in the U.K. quit nicotine each year.

A study of more than 100,000 urban commuters in China suggests that walking or cycling to work can lower people’s risk of ischemic heart disease (IHD) and stroke, even when factoring in the “rather serious air pollution” in the country.